Ridaforolimus With Cetuximab: Adv Non-Small Cell Lung, Colorectal, Head & Neck Cancer

NCT01212627 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
12
Enrollment
OTHER
Sponsor class

Stopped Determination to stop enrollment made due to funding

Conditions

Interventions

Sponsor

Angela Taber MD

Collaborators